|
My heart siiiiiiiinks
|
# ? Jul 14, 2019 18:52 |
|
|
# ? Apr 27, 2024 06:49 |
|
HOW HOW DO YOU DO THAT
|
# ? Jul 14, 2019 18:52 |
|
Both players challenging reminds me of the ginobili harden double flop
|
# ? Jul 14, 2019 18:52 |
|
chris fowler: welcome to the 47th tiebreaker [sun rises] [sun keeps getting bigger] fowler: yes [world engulfed by flames] fowler: oh god yes
|
# ? Jul 14, 2019 18:54 |
|
eternal sunshine of the spotless deuce
|
# ? Jul 14, 2019 18:54 |
|
One way to avoid the tiebreaker is to just play at 11-11 forever
|
# ? Jul 14, 2019 18:55 |
|
Pleeesssse
|
# ? Jul 14, 2019 18:55 |
|
A loving tie break...
|
# ? Jul 14, 2019 18:58 |
|
loving hell this is too much
|
# ? Jul 14, 2019 18:58 |
|
Tiebreaker yesssss
|
# ? Jul 14, 2019 18:59 |
|
Lmao djokovic
|
# ? Jul 14, 2019 18:59 |
|
Schlub Husband posted:A loving tie break... Prepare the OpEds of how THIS. IS. NOT. GRAND. SLAM. FINALS. TENNIS.
|
# ? Jul 14, 2019 18:59 |
|
Wow, that looked easy.
|
# ? Jul 14, 2019 19:00 |
|
Dkokovic that was clearly in you tooo
|
# ? Jul 14, 2019 19:00 |
|
Djokovic is ALL CAPS MAD
|
# ? Jul 14, 2019 19:01 |
|
AHHHHHHHHHHHHHHHHH
|
# ? Jul 14, 2019 19:01 |
|
play it out you cowards
|
# ? Jul 14, 2019 19:01 |
|
The record books for this event will show Federer didn't drop a game and lost the match. Break and break back in the fifth cancel each other out.
|
# ? Jul 14, 2019 19:02 |
|
Whelp
|
# ? Jul 14, 2019 19:02 |
|
|
# ? Jul 14, 2019 19:03 |
|
lmao he missed the ground with his foot
|
# ? Jul 14, 2019 19:03 |
|
This is not Wimbledon.
|
# ? Jul 14, 2019 19:06 |
|
and the worse player wins, in accordance with the purpose of the sporting competition
|
# ? Jul 14, 2019 19:08 |
|
Djokovic is like a cockroach and Federer didn't step on him at match point.
|
# ? Jul 14, 2019 19:08 |
|
Sucks
|
# ? Jul 14, 2019 19:08 |
|
Boo
|
# ? Jul 14, 2019 19:08 |
|
gently caress tennis forever
|
# ? Jul 14, 2019 19:08 |
|
Evil has won. Darkness sets in. gently caress everything
|
# ? Jul 14, 2019 19:08 |
|
Jesus
|
# ? Jul 14, 2019 19:09 |
|
gently caress
|
# ? Jul 14, 2019 19:09 |
|
Owned
|
# ? Jul 14, 2019 19:09 |
|
gently caress this
|
# ? Jul 14, 2019 19:09 |
|
Continuous erythropoietin receptor activator (CERA) is the generic term for drugs in a new class of third-generation erythropoiesis-stimulating agents (ESAs). In the media, these agents are commonly referred to as 'EPO', short for erythropoietin. CERAs have an extended half-life and a mechanism of action that promotes increased stimulation of erythropoietin receptors compared with other ESAs. Under the trade name Mircera, Roche Pharmaceuticals received approval from the U.S. Food and Drug Administration (FDA) in January 2008 to market a continuous erythropoiesis receptor activator (methoxy polyethylene glycol-epoetin beta) for the treatment of anemia in patients with chronic kidney disease, including in those undergoing dialysis.[1] (Patent disputes between Amgen, which owns several patents relating to recombinant EPO variants, and Roche are blocking distribution of Mircera in the U.S.[citation needed] This issue appears to have been resolved since Fresenius Medical dialysis clinics in the US are now administering this drug.[citation needed]) Methoxy polyethylene glycol-epoetin beta had been approved by the European Commission in August 2007, and was made available in Europe at the start of 2008.[citation needed] In terms of its structure, Mircera is similar to the previous synthetic EPO drugs, except that it is connected to a chemical called polyethylene glycol (PEG), which makes it last longer in the body. According to Roche, the product has the longest half-life of all FDA-approved erythropoiesis-stimulating agents (ESAs): up to 6 times longer than darbepoetin alfa and up to 20 times longer than epoetin. CERAs thus promise both lower dosing—significant owing to the high inherent cost of manufacturing recombinant protein drugs—and less frequent injections for patients. ESAs are administered via subcutaneous injections, often in doctor's offices for patients who lack the skill or dexterity to inject themselves, so the once- or twice-monthly dosing regimen for CERAs promises fewer costly, inconvenient office visits for patients requiring constant hemoglobin level maintenance for chronic kidney disease. In clinical trials, CERA dosed every 3 to 4 weeks demonstrated efficacy similar to that of epoetin alfa and darbepoetin alfa in maintaining hemoglobin concentrations within the target hemoglobin range. CERA has generally been well tolerated in clinical trials.[citation needed]
|
# ? Jul 14, 2019 19:10 |
|
worst possible outcome
|
# ? Jul 14, 2019 19:10 |
|
So yeah that tie breaker rule is loving bollocks.
|
# ? Jul 14, 2019 19:10 |
|
The passing of the GOAT looms ever nearer
|
# ? Jul 14, 2019 19:10 |
|
Feels Villeneuve posted:Continuous erythropoietin receptor activator (CERA) is the generic term for drugs in a new class of third-generation erythropoiesis-stimulating agents (ESAs). In the media, these agents are commonly referred to as 'EPO', short for erythropoietin. CERAs have an extended half-life and a mechanism of action that promotes increased stimulation of erythropoietin receptors compared with other ESAs. Agreed. What a terrible day for sports.
|
# ? Jul 14, 2019 19:11 |
|
Djokovic coming back from 2 championship points down on Federer’s serve is unbelievable. Like I had given the title to Federer at that point. I wonder what the live betting odds were.
|
# ? Jul 14, 2019 19:11 |
|
Roger how do you blow 2 championships on serve gently caress
|
# ? Jul 14, 2019 19:11 |
|
|
# ? Apr 27, 2024 06:49 |
|
This must be the end of Federers career. He'lll never recover from this humiliation, and neither will I gonna cry now
|
# ? Jul 14, 2019 19:11 |